Nuris Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Nuris Pharma Private Limited

Nuris Pharma Private Limited, a active private limited company, was established on 29 August 2016 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24290MH2016PTC285232. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Babita Sanjay Bhandari (Director), Trupti Jayant Gosalia (Director). Past directors included Babita Sanjay Bhandari, Smita Tarun Modi. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Lower Level-6, L L-6, Hi Life, P.M.Street, Santacruz West,, Mumbai, Maharashtra, 400054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MH2016PTC285232

  • Registration Number

    285232

  • Incorporation Date

    29 August 2016

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 298.84%
  • Profit Growth **** -178.33%
  • Ebitda **** 1696.09%
  • Net Worth -0.54%
  • Total Assets -0.68%
Company report

Nuris Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nuris Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nuris Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Babita Sanjay Bhandari Director 02 Feb 2024 Current
Trupti Jayant Gosalia Director 29 Aug 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 16 Dec 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nuris Pharma.

Nuris Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 298.84% increase. The company also saw a substantial fall in profitability, with a 178.33% decrease in profit. The company's net worth dipped by a decrease of 0.54%.

Nuris Pharma revenue growth over time
Nuris Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 298.84%
*******
*******
*******
*******
Revenue from Operations
*******
 298.84%
*******
*******
*******
*******
Total Assets
*******
 -0.68%
*******
*******
*******
*******
Profit or Loss
*******
 -178.33%
*******
*******
*******
*******
Net Worth
*******
 -0.54%
*******
*******
*******
*******
EBITDA
*******
 1696.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nuris Pharma?

In 2020, Nuris Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nuris Pharma?

Unlock and access historical data on people associated with Nuris Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nuris Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuris Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nuris Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nuris Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Nuris Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Babita Sanjay Bhandari was appointed as a Director was appointed as a Director on 02 Feb 2024 & has been associated with this company since 2 years 10 days . was documented.

  • Director Appointment

    The activity Trupti Jayant Gosalia was appointed as a Director was appointed as a Director on 29 Aug 2016 & has been associated with this company since 9 years 5 months . was completed.

  • Company Incorporation

    The activity Nuris Pharma Private Limited was registered on 29 Aug 2016 with Roc Mumbai & aged 9 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nuris Pharma Private Limited?

The CIN of Nuris Pharma Private Limited is U24290MH2016PTC285232.

Where is Nuris Pharma Private Limited headquartered?

Nuris Pharma Private Limited is headquartered at Lower Level-6, L L-6, Hi Life, P.M.Street, Santacruz West,, Mumbai, Maharashtra, 400054.

When was Nuris Pharma Private Limited incorporated?

Nuris Pharma Private Limited was incorporated on 29 August 2016.

Who are the current directors of Nuris Pharma Private Limited?

The current directors of Nuris Pharma Private Limited are

What is the primary industry of Nuris Pharma Private Limited?

The primary industry of Nuris Pharma Private Limited is Manufacturing.

Is Nuris Pharma Private Limited a listed company?

Nuris Pharma Private Limited is unlisted.

What is the capital structure of Nuris Pharma Private Limited?

The authorized capital of Nuris Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Nuris Pharma Private Limited?

The compliance status of Nuris Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available